World Medicine Limited in London, N3 2JU

Description

Data updated on: 01-11-2023

World Medicine is a firm with it's headquarters at N3 2JU London at Ground Floor, Gadd House Arcadia Avenue. The company has been in existence since 2004 and is registered under the registration number 05285277. The company has been active on the UK market for 20 years now and its state is active. This firm's principal business activity number is 46460 meaning Wholesale of pharmaceutical goods. World Medicine Ltd filed its account information for the period up to Saturday 31st December 2022. The firm's latest annual confirmation statement was submitted on Wednesday 21st June 2023.

Concerning this limited company, the full extent of director's obligations have so far been carried out by Serkan U. who was appointed in 2023. This limited company had been managed by Rafael T. up until September 2023. As a follow-up another director, including Raushan T. gave up the position in October 2022. In order to support the directors in their duties, this limited company has been utilizing the expertise of Serkan U. as a secretary since September 2023.

Financial data based on annual reports

Profit & Loss
Date of Accounts	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31
Currency

Balance Sheet
Cash Bank On Hand	71 462	168 726	78 996	106 694	93 199	8 670
Current Assets	2 659 933	3 227 711	3 172 195	1 206 278	1 322 250	884 569
Debtors	2 588 471	3 058 985	3 093 199	1 099 584	1 229 051	875 899
Net Assets Liabilities	1 218 859	812 563	786 898	630 229
Other Debtors		18 215	18 215	18 215	236 360	29 001
Property Plant Equipment		5 436	20 888	15 394	9 902	273

Other Financial Data
Audit Fees Expenses	4 000	4 000	4 180	4 000
Accrued Liabilities Deferred Income	6 100	6 100	6 280	6 200
Accumulated Amortisation Impairment Intangible Assets	128 712	143 497	147 853	147 853	147 853
Accumulated Depreciation Impairment Property Plant Equipment		1 359	6 581	12 075	17 567	18 926
Additions Other Than Through Business Combinations Property Plant Equipment		6 795	20 674
Administration Support Average Number Employees	5	5
Administrative Expenses	157 787	167 271	225 144	204 363
Amortisation Expense Intangible Assets	14 785	14 785	4 356
Amounts Owed By Group Undertakings Participating Interests				1 177
Amounts Owed By Related Parties				1 177
Amounts Owed To Group Undertakings Participating Interests		223 108
Applicable Tax Rate		19	19	19
Average Number Employees During Period		5	5	5	5	5
Corporation Tax Payable	11 522	24 930	32 762			9 460
Corporation Tax Recoverable				12 338	1 539	1 332
Cost Sales	3 689 971	13 068 569	14 088 145	2 887 717
Creditors	1 560 215	2 524 940	2 506 185	691 443	760 290	937 057
Current Tax For Period	11 522	31 315	32 762	5 851
Depreciation Expense Property Plant Equipment		1 359	5 222	5 494
Distribution Costs	4 576	14 597	4 130	3 664
Dividends Paid		522 925	157 102	177 280
Fixed Assets	119 141	109 792	120 888	115 394	109 902	100 273
Future Minimum Lease Payments Under Non-cancellable Operating Leases			103 640	57 578
Gross Profit Loss	127 751	268 538	518 156	164 168
Increase From Amortisation Charge For Year Intangible Assets		14 785	4 356
Increase From Depreciation Charge For Year Property Plant Equipment		1 359	5 222	5 494	5 492	1 359
Intangible Assets	19 141	4 356
Intangible Assets Gross Cost	147 853	147 853	147 853	147 853	147 853
Investments Fixed Assets	100 000	100 000	100 000	100 000	100 000	100 000
Investments In Subsidiaries	100 000	100 000	100 000	100 000
Net Assets Liabilities Associates		197 942	164 992	105 652
Net Current Assets Liabilities	1 099 718	702 771	666 010	514 835	561 960	-52 488
Nominal Value Allotted Share Capital	2	2	2	2
Number Shares Issued Fully Paid		2	2	2
Operating Profit Loss	106 116	147 886	164 194	26 442
Other Creditors		4 400		26 290	16 480	14 085
Other Disposals Property Plant Equipment						8 270
Other Interest Receivable Similar Income Finance Income	5	58	5	20
Other Investments Other Than Loans				100 000	100 000	100 000
Other Operating Income Format1	140 728	61 216	-124 688	70 301
Par Value Share		1	1	1
Percentage Class Share Held In Associate		100	100	100
Prepayments Accrued Income			14 010	14 122
Profit Loss	94 599	116 629	131 437	20 611
Profit Loss From Continuing Operations Associates		16 002	52 127	-59 340
Profit Loss On Ordinary Activities Before Tax	106 121	147 944	164 199	26 462
Property Plant Equipment Gross Cost		6 795	27 469	27 469	27 469	19 199
Revenue From Sale Goods	3 817 722	13 337 107	14 606 301	3 051 885
Social Security Costs	86
Staff Costs Employee Benefits Expense	86
Tax Expense Credit Applicable Tax Rate		28 109	31 198	5 028
Tax Increase Decrease From Effect Capital Allowances Depreciation		-1 033	737
Tax Increase Decrease From Effect Expenses Not Deductible For Tax Purposes Other Than Goodwill Amortisation Impairment		4 239	827	823
Tax Tax Credit On Profit Or Loss On Ordinary Activities	11 522	31 315	32 762	5 851
Total Assets Less Current Liabilities				630 229	671 862	47 785
Total Current Tax Expense Credit		31 315	32 762	5 851
Trade Creditors Trade Payables	1 524 161	1 982 828	2 447 055	665 155	743 810	913 512
Trade Debtors Trade Receivables	2 518 173	2 458 262	2 706 872	584 923	972 937	815 892
Turnover Revenue	3 817 722	13 337 107	14 606 301	3 051 885

Company staff

Serkan U.

Role: Director

Appointed: 04 September 2023

Latest update: 9 March 2024

Rafael T. is the individual with significant control over this firm, owns over 3/4 of company shares and has 3/4 to full of voting rights.

Rafael T.

Notified on 12 May 2022

Nature of control:

over 3/4 of shares

3/4 to full of voting rights

right to manage directors

Raushan T.

Notified on 21 October 2016

Ceased on 12 May 2022

Nature of control:

over 3/4 of shares

Accounts Documents

Account next due date	30 September 2024
Account last made up date	31 December 2022
Confirmation statement next due date	05 July 2024
Confirmation statement last made up date	21 June 2023

Annual Accounts
Start Date For Period Covered By Report	2018-01-01
End Date For Period Covered By Report	31 December 2018
Annual Accounts
Start Date For Period Covered By Report	2019-01-01
End Date For Period Covered By Report	31 December 2019
Annual Accounts
Start Date For Period Covered By Report	2020-01-01
End Date For Period Covered By Report	31 December 2020
Annual Accounts
Start Date For Period Covered By Report	2021-01-01
End Date For Period Covered By Report	2021-12-31
Annual Accounts
Start Date For Period Covered By Report	2022-01-01
End Date For Period Covered By Report	2022-12-31

World Medicine Limited

General information

Name:

Office Address:

Description

Financial data based on annual reports

Company staff

Serkan U.

Serkan U.

Rafael T.

Rafael T.

Zafer K.

Raushan T.

Paul W.

Zafer K.

Zafer K.

Edward P.

Sarah P.

People with significant control

Rafael T.

Raushan T.

Accounts Documents

Company filings

Filing category

Search other companies

Services (by SIC Code)

Company Age

Similar companies nearby

Closest companies